CompanyTrack
Sign Up Log In
E

EVESTIA CLINICAL LIMITED

Active Letchworth Garden City

Research and experimental development on biotechnology

55 employees Website
Life sciences and medical technology Research and experimental development on biotechnologyOther human health activities
E

EVESTIA CLINICAL LIMITED

Research and experimental development on biotechnology

Founded 17 Apr 1996 Active Letchworth Garden City, England 55 employees evestiaclinical.com
Life sciences and medical technology Research and experimental development on biotechnologyOther human health activities
Accounts Submitted 6 Oct 2025
Confirmation Statement Submitted 14 Aug 2025
Net assets £-1.25M £115.00K 2023 year on year
Total assets £7.64M £1.90M 2023 year on year
Total Liabilities £8.88M £1.79M 2023 year on year
Charges 10
2 outstanding 8 satisfied

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Suite 209 The Spirella Building Bridge Road Letchworth Garden City Herts SG6 4ET England

Telephone

0(0)1462424400

Credit Report

Discover EVESTIA CLINICAL LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2014–2023)

Cash in Bank

£77.00k

Decreased by £1.34M (-95%)

Net Assets

-£1.25M

Increased by £115.00k (+8%)

Total Liabilities

£8.88M

Increased by £1.79M (+25%)

Turnover

£10.71M

Increased by £1.45M (+16%)

Employees

55

Decreased by 27 (-33%)

Debt Ratio

116%

Decreased by 8 (-6%)
See 10 Year Full Financials

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 1,798 Shares £1.59m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
6 Dec 20241,000£1.59m£2k
30 Nov 2014320£3.2£0.01
30 Nov 2013215£462.25£2.15
15 Feb 2013263£2.63£0.01

Officers

Officers

4 active 20 resigned
Status
Carl HvassDirectorBritishEngland517 Dec 2024Active
Lewis CameronDirectorBritishEngland627 Dec 2024Active
Richard Timothy BarfieldDirectorBritishEngland687 Dec 2024Active
Roy Michael OvelDirectorBritishEngland627 Dec 2024Active

Shareholders

Shareholders (6)

Project Barcelona Bidco Limited
89.0%
11,00014 Aug 2025
Project Barcelona Bidco Limited
8.8%
1,08314 Aug 2025
Project Barcelona Bidco Limited
2.2%
27814 Aug 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Project Barcelona Bidco Limited

Unknown

Active
Notified 7 Dec 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Bionical Limited

Ceased 7 Dec 2024

Ceased
See All Controllers

Group Structure

Group Structure

PROJECT BARCELONA BIDCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent
PROJECT BARCELONA MIDCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent
PROJECT BARCELONA TOPCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent
KESTER CAPITAL III GP LLP united kingdom voting rights 25 to 50 percent limited liability partnership, right to share surplus assets 25 to 50 percent limited liability partnership
GCP EUROPE GP1 LTD united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
GCP EUROPE GP2 LTD united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
KESTER CAPITAL LLP united kingdom
EVESTIA CLINICAL LIMITED Current Company

Charges

Charges

2 outstanding 8 satisfied

Documents

Company Filings

DateCategoryDescriptionDocument
6 Oct 2025AccountsAnnual accounts made up to 2024-12-31View(35 pages)
22 Aug 2025MortgageMortgage Create With Deed With Charge Number Charge Creation DateView(76 pages)
22 Aug 2025MortgageMortgage Satisfy Charge FullView(1 page)
22 Aug 2025MortgageMortgage Satisfy Charge FullView(1 page)
15 Aug 2025MortgageMortgage Create With Deed With Charge Number Charge Creation DateView(65 pages)
6 Oct 2025 Accounts

Annual accounts made up to 2024-12-31

View Document(35 pages)
22 Aug 2025 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

View Document(76 pages)
22 Aug 2025 Mortgage

Mortgage Satisfy Charge Full

View Document(1 page)
22 Aug 2025 Mortgage

Mortgage Satisfy Charge Full

View Document(1 page)
15 Aug 2025 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

View Document(65 pages)

Recent Activity

Latest Activity

Annual accounts made up to 2024-12-31

4 months ago on 6 Oct 2025

Mortgage Create With Deed With Charge Number Charge Creation Date

5 months ago on 22 Aug 2025

Mortgage Satisfy Charge Full

5 months ago on 22 Aug 2025

Mortgage Satisfy Charge Full

5 months ago on 22 Aug 2025

Mortgage Create With Deed With Charge Number Charge Creation Date

6 months ago on 15 Aug 2025